Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P08123: Variant p.Thr59Pro

Collagen alpha-2(I) chain
Gene: COL1A2
Feedback?
Variant information Variant position: help 59 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Threonine (T) to Proline (P) at position 59 (T59P, p.Thr59Pro). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (T) to medium size and hydrophobic (P) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 59 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1366 The length of the canonical sequence.
Location on the sequence: help GPRGERGPPGPPGRDGEDGP T GPPGPPGPPGPPGLGGNFAA The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         GPRGERGPPGPPGRDGEDGPTGPP------GPPGPPGPPGLGGNFAA

                              GPRGERGPPGPPGRDGDDGIPGPP------GPPGPPGPPGL

Mouse                         GPRGQRGPAGPRGRDGVDGPMGPPGPPGSPGPPGSPAPPGL

Rat                           GPRGQRGPAGPRGRDGVDGPVGPPGPPGAPGPPGPPGPPGL

Bovine                        GPRGERGPPGPPGRDGDDGIPGPP------GPPGPPGPPGL

Chicken                       GPQGERGPPGPPGRDGED---GPP------GPPGPPGPPGL

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Propeptide 23 – 79 N-terminal propeptide
Region 28 – 1130 Disordered
Compositional bias 43 – 72 Pro residues
Modified residue 47 – 47 4-hydroxyproline
Modified residue 50 – 50 4-hydroxyproline
Modified residue 62 – 62 4-hydroxyproline
Modified residue 65 – 65 4-hydroxyproline
Modified residue 68 – 68 4-hydroxyproline
Modified residue 71 – 71 4-hydroxyproline



Literature citations
Analysis of the promoter region and the N-propeptide domain of the human pro alpha 2(I) collagen gene.
Dickson L.A.; de Wet W.; Di Liberto M.; Weil D.; Ramirez F.;
Nucleic Acids Res. 13:3427-3438(1985)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-93; VARIANT PRO-59;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.